About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Anti-androgen Therapy may Benefit Bladder Cancer Patients

by Sheela Philomena on September 25, 2012 at 10:19 AM
Font : A-A+

 Anti-androgen Therapy may Benefit Bladder Cancer Patients

Bladder cancer patients whose tumors express high levels of the protein CD24 may benefit from anti-androgen therapies, say researchers.

"This is a major finding - bladder cancer development and spread to other organs depends significantly on CD24, which in turn depends on androgens like testosterone. By taking away these androgens, we may be able to greatly diminish the proliferative and metastatic power of bladder cancer cells," says the study's senior author, Dan Theodorescu, MD, PhD, director of the University of Colorado Cancer Center.

Advertisement

Theodorescu and colleagues started with mouse models, showing that mice without the ability to make the protein CD24 had fewer primary bladder tumors and metastases (bladder tumor spread to other organs) compared to mice with CD24 intact. This effect was most marked in male mice. The group moved to human tumor samples, showing that when patients were stratified according to the levels of CD24 expressed in their tumors, especially the male patients had poorer outcomes, including higher rates of relapse and shorter disease-free survival.

"To us, these sex-specific findings implied androgen involvement," Theodorescu says. Sure enough, when the group knocked down androgen receptors in human bladder cancer cell lines, they saw a corresponding drop in CD24 levels and also decreased cell proliferation. When they artificially added CD24, cell proliferation resumed regardless of androgen levels. In essence, androgen is effectively a hormonal switch that allowed the harmful effect of CD24 to flow.
Advertisement

Together, these finding imply not only a correlative but a causative effect of CD24 - that not only do high levels of CD24 mark more aggressive bladder tumors, but that CD24 in fact drives the aggressiveness of these tumors. While the protein CD24 is difficult to affect directly with current therapies, anti-androgen therapies that would diminish the tumor's ability to express CD24 are already in wide use for prostate cancer.

"We hope the results of these studies show the rationale for clinical studies of anti-androgen therapies with bladder cancer, especially in those tumors that happen to test markedly high in CD24 expression," Theodorescu says. "The next step is moving this promising therapy to clinical trials with human patients."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test your Knowledge on Heart Transplantation
Test Your Knowledge on Lung Transplantation
Baldness can be Cured and Prevented: let us see How!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Vesico-Ureteric Reflux Causing UTI in Children Enuresis/Bedwetting Reiki and Pranic Healing Cancer Facts Cancer Tattoos A Body Art Interstitial Cystitis Bladder Cancer Common Lifestyle Habits that Cause Diseases 

Most Popular on Medindia

Indian Medical Journals Nutam (400mg) (Piracetam) Noscaphene (Noscapine) Drug - Food Interactions Daily Calorie Requirements Turmeric Powder - Health Benefits, Uses & Side Effects A-Z Drug Brands in India Calculate Ideal Weight for Infants Color Blindness Calculator Pregnancy Confirmation Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use